01 1Zhejiang Haisen Pharmaceutical Co., Ltd.
01 1ESCITALOPRAM OXALATE
01 1China
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2025-04-23
Pay. Date : 2025-03-17
DMF Number : 40923
Submission : 2025-01-25
Status : Active
Type : II
20
Zhejiang Haisen Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is ESCITALOPRAM OXALATE, with a corresponding US DMF Number 40923.
Remarkably, this DMF maintains an Active status since its submission on January 25, 2025, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 23, 2025, and payment made on March 17, 2025, indicating their dedication to facilitating drug approvals, Categorized as Type II
